We’re now entering the second week of the shutdown of the federal government (or “the lapse period” as some have called it), and there does not appear to be an end in sight. In fact, the environment in Washington, D.C. has been described as “toxic.” On the FDA front, confusion (both in and out of the Agency) seems to have been the state of affairs for several days last week. What’s on and what’s off for FDA has been an ongoing topic of discussion since before the shutdown and after FDA issued an initial statement on affected activities (see our previous posthere).
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Showing posts with label FDA LAW BLOG--October 07. Show all posts
Showing posts with label FDA LAW BLOG--October 07. Show all posts
Tuesday, October 8, 2013
Subscribe to:
Posts (Atom)